The National Comprehensive Cancer Network has published new patient-friendly breast cancer screening guidelines

New breast cancer screening guidelines published by the National Comprehensive Cancer Network put emphasis on the age at which average women should begin annual screening. 

NCCN maintains that women at average risk (no known genetic risk of family history) should begin undergoing annual mammograms at the age of 40, and that all women should start breast cancer risk assessments through their primary healthcare provider starting at age 25 and continuing every 1 to 3 years thereafter. These assessments gauge a woman’s risk of developing cancer during her lifetime and include a rundown of family history, blood work, discussing any changes pertaining to the breasts as well as a breast exam. 

“There are many, often conflicting, recommendations surrounding breast cancer screening, which causes a lot of confusion and apprehension,” Therese Bevers, MD, who is a Professor of Clinical Cancer Prevention at the University of Texas MD Anderson Cancer Center and Chair with the NCCN Guidelines Panel for Breast Cancer Screening and Diagnosis, said in a release. “These are the latest, evidence-based guidelines from experts in the field of breast cancer screening and diagnosis from more than two dozen leading cancer centers in the United States.”

Other key NCCN recommendations include undergoing 3D mammography when possible, continuing annual screenings during pregnancy with the protection of a lead shield and including breast MRI exams in clinical protocols for women who are at an increased risk of developing cancer.  

“Annual mammography screening beginning at age 40 is associated with the highest mortality reduction for average risk women,” said Mark Helvie, MD, who is a member of the NCCN Guidelines Panel for Breast Cancer Screening and Diagnosis, and professor of radiology and director of the breast imaging division, University of Michigan Rogel Cancer Center. “Having a mammogram at infrequent or irregular intervals limits its effectiveness. For women at increased risk, the NCCN Guidelines recommend starting screening earlier and often include breast MRI in addition to mammography.” 

These most recent recommendations are the latest addition to the NCCN’s library of cancer screening guidelines. They are written in easy-to-understand, patient-friendly language and offer women a plethora of individualized information pertaining to their risks and screening recommendations.  

They are available for free here.

Hannah murhphy headshot

In addition to her background in journalism, Hannah also has patient-facing experience in clinical settings, having spent more than 12 years working as a registered rad tech. She joined Innovate Healthcare in 2021 and has since put her unique expertise to use in her editorial role with Health Imaging.

Around the web

The two companies aim to improve patient access to high-quality MRI scans by combining their artificial intelligence capabilities.

Positron, a New York-based nuclear imaging company, will now provide Upbeat Cardiology Solutions with advanced PET/CT systems and services. 

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.